
ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings
Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Appointment of Administrators & Nomad Resignation | 2025-03-26 | English | |
| Holding(s) in Company | 2025-03-19 | English | |
| Intention to Appoint Administrators and Suspension | 2025-03-17 | English | |
| Block Listing Return | 2025-03-14 | English | |
| Result of GM | 2025-03-10 | English | |
| Result of AGM | 2025-02-27 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 6770030 | Appointment of Administrators & Nomad Resignation | 2025-03-26 | English | ||
| 5594783 | Holding(s) in Company | 2025-03-19 | English | ||
| 5593384 | Intention to Appoint Administrators and Suspension | 2025-03-17 | English | ||
| 5592659 | Block Listing Return | 2025-03-14 | English | ||
| 5589562 | Result of GM | 2025-03-10 | English | ||
| 5584360 | Result of AGM | 2025-02-27 | English | ||
| 46831556 | Group of companies' accounts made up to 2024-08-31 | 2025-02-25 | English | ||
| 5582904 | Strategic update | 2025-02-24 | English | ||
| 5580577 | Holding(s) in Company | 2025-02-18 | English | ||
| 5578356 | Block Listing Return | 2025-02-12 | English | ||
| 5578364 | Posting of Notice of General Meeting | 2025-02-12 | English | ||
| 5577315 | Final Results | 2025-02-10 | English | ||
| 5574782 | Holding(s) in Company | 2025-02-04 | English | ||
| 5574198 | Notice of Annual General Meeting | 2025-02-03 | English | ||
| 5573375 | Trading Update | 2025-01-31 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ONCIMMUNE HOLDINGS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Perseus Proteomics Inc.
Develops antibody-based therapeutics, diagnostics, and rese…
|
4882 | JP | Professional, scientific and te… |
|
PExA AB
Develops non-invasive technology for respiratory medicine b…
|
PEXA B | SE | Professional, scientific and te… |
|
PharmaResources (Shanghai) Co., Ltd.
Integrated CRO and CDMO for small molecule drug discovery a…
|
301230 | CN | Professional, scientific and te… |
|
Pharmaron Beijing Co., Ltd
Delivers integrated R&D and manufacturing across the entire…
|
3759 | HK | Professional, scientific and te… |
|
Pharmaron Beijing Co., Ltd.
Integrated R&D provider for drug discovery, development, an…
|
300759 | CN | Professional, scientific and te… |
|
Pharos iBio Co., Ltd.
Clinical-stage biotech using AI to develop therapies for ra…
|
388870 | KR | Professional, scientific and te… |
|
Pherecydes Pharma
A clinical-stage biotech company developing phage therapy f…
|
ALPHE | FR | Professional, scientific and te… |
|
PhoenixBio Co.,Ltd.
A CRO providing humanized liver mouse models for preclinica…
|
6190 | JP | Professional, scientific and te… |
|
PHOENIX INTERNATIONAL LIFE SCIENCES
Advancing healthcare research using AI analytics, at-home t…
|
PLSI | CA | Professional, scientific and te… |
|
PILA PHARMA AB
Clinical-stage biotech developing an oral TRPV1 antagonist …
|
PILA | SE | Professional, scientific and te… |
ONCIMMUNE HOLDINGS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7820/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7820 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7820 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7820 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7820}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ONCIMMUNE HOLDINGS PLC (id: 7820)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.